Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 12-2019 | 06-2019 | 12-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,885 | 4,402 | 3,886 | 3,879 | 4,618 |
| Receivables | 908 | 636 | 1,223 | 2,332 | 1,966 |
| Other current assets | 361 | 124 | 265 | 103 | 595 |
| TOTAL | $7,154 | $5,162 | $5,374 | $6,315 | $7,179 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 120 | 0 | 3,361 |
| Other Non-Current Assets | 8,333 | 8,859 | 9,651 | 0 | 11,303 |
| TOTAL | $8,333 | $8,859 | $9,771 | $N/A | $14,664 |
| Total Assets | $15,487 | $14,022 | $15,145 | $18,350 | $21,844 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,343 | 2,009 | 1,262 | 0 | 1,603 |
| Other current liabilities | 1,060 | 106 | 98 | N/A | 1,411 |
| TOTAL | $3,403 | $2,114 | $1,359 | $1,740 | $3,014 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 307 | 0 | 980 | 0 | 0 |
| TOTAL | $2,599 | $3,525 | $3,634 | $N/A | $3,912 |
| Total Liabilities | $6,002 | $5,639 | $4,993 | $5,183 | $6,926 |
| Shareholders' Equity | |||||
| Common Shares | 32,757 | 27,620 | 26,206 | N/A | 24,481 |
| Retained earnings | -24,299 | -21,087 | -17,843 | -14,844 | -11,351 |
| Other shareholders' equity | 1,027 | 1,850 | 1,789 | 28,010 | 1,788 |
| TOTAL | $9,485 | $8,383 | $10,152 | $13,166 | $14,918 |
| Total Liabilities And Equity | $15,487 | $14,022 | $15,145 | $18,350 | $21,844 |